#¼ÛµµÇÑÆ÷Áø, #¼ÛµµÇÑÆ÷ÁøÇÑÀÇ¿ø, #¾ÆÅäÇǼºÇǺο°, #¼Ûµµ¾ÆÅäÇǼºÇǺο°, #ÇÑÆ÷ÁøÇÑÀÇ¿ø, #¾ÆÅäÇǼºÇǺο°ÇÑÀÇ¿ø, #¼Ûµµ¾ÆÅäÇǼºÇǺο°, #±¸¿ùµ¿ÇÑÆ÷Áø
¼ÛµµÇÑÆ÷Áø,,¼ÛµµÇÑÆ÷ÁøÇÑÀÇ¿ø,,¾ÆÅäÇǼºÇǺο°,,¼Ûµµ¾ÆÅäÇǼºÇǺο°,,ÇÑÆ÷ÁøÇÑÀÇ¿ø,,¾ÆÅäÇǼºÇǺο°ÇÑÀÇ¿ø,,¼Ûµµ¾ÆÅäÇǼºÇǺο°,,±¸¿ùµ¿ÇÑÆ÷Áø
¾È³çÇϼ¼¿ä. ¼ÛµµÇÑÆ÷Áø ±¸¿ùµ¿ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä
¼ÛµµÇÑÆ÷Áø ±¸¿ùµ¿ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â¾ÆÅäÇǼºÇǺο°, ¾Ë·¹¸£±â¼ºÀÚ¹ÝÁõ, Áö·ç¼ºµÎÇÇ¿°, ȯÀý±âÇǺΰǼ±, ż±, À¯¾ÆÁ¢Ã˼ºÇǺο°, õÆ÷â, ¼Õ°¡¶ô°Ç¼±, Àü½Å¼º³óÆ÷°Ç¼±, ¼Õ»ç¸¶±Í, ÇǺΰ£Áö·¯¿ò, ¼ÕÅé°Ç¼±, ÇǺΰ¡·Á¿òÁõÄ¡·á, ¾î¸¥¾ÆÅäÇÇ, ¾Æ±â¼Õ°¡¶ô½ÀÁø, ¾ÆÅäÇǾà, °Ç¼±Ä¡·áÇÑÀÇ¿ø, »çŸ±¸´Ï°¡·Á¿òÁõ, ¹ß¹Ù´ÚÇÑÆ÷Áø, ¼Õ¸ñ¿¡µÎµå·¯±â, À¯¾Æ»ç¸¶±Í, ÈÆó½ÀÁø, Àü½Å¼º°Ç¼º, ³óÆ÷¼º°Ç¼±, ¼Õ¹Ù´Ú°¡·Á¿òµî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù.
¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó ´ÜÆÄÅõ¿Ä¡·á, ¿äÃß°ßÀÎÄ¡·á, ÁÂÈÆ¿ä¹ý, ¸Æ¹Ý¼®¿Â½ÀÂòÁú±â, µµÀοä¹ý, »öä¿ä¹ý, Çâ±âºÐ»ç¿ä¹ý, °üÀýº¸È£´ë, paraffin, ¿îµ¿Ä¡·á, Çâ±â±¤¼±¿ä¹ý, ºñ¸¸Àüħ, ºÀħ, °æ¶ôÇâ±â¿ä¹ý, ·ÑÇÎ, ¾àħ¼ú, ü¼ººÐºÐ¼®, ü¿Áø´Ü(ºÎºÐ), ºÀ¾àħ, ´Ü¼ø±³Á¤Ãß³ª, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù
¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼ Áø·áÁßÀÌ¸ç °æ³² ÁøÁֽà Æò°Åµ¿, ÀÎõ ¿¬¼ö±¸ µ¿Ãá1µ¿, °æ³² â¿ø½Ã ¼º»ê±¸ Åä¿ùµ¿, ÀÎõ Áß±¸ ¼ÛÇе¿1°¡, ¿ï»ê Áß±¸ ¿ìÁ¤µ¿, ÀÎõ ³²µ¿±¸ °£¼®2µ¿, °æ±â ½ÃÈï½Ã ¹°¿Õµ¿, °æºÏ ¿¹Ãµ±º Çϸ®¸é, °æ±â µ¿µÎõ½Ã »ý¿¬2µ¿, ¿ï»ê ³²±¸ Ȳ¼ºµ¿, °æ±â ¼º³²½Ã ºÐ´ç±¸ ¼º³²ºÐ´ç¿ìü±¹»ç¼ÇÔ, ºÎ»ê ¼±¸ Ã湫µ¿1°¡, °æ³² ±èÇؽà »óµ¿¸é, °æºÏ »óÁֽà ÇÔâÀ¾, ºÎ»ê ¼ö¿µ±¸ ¸Á¹Ì2µ¿, °æºÏ ±èõ½Ã Á¶¸¶¸é, ÀüºÏ ±º»ê½Ã ³ª¿î1µ¿, Ãæ³² º¸·É½Ã ´ëõ2µ¿, ÀüºÏ ³²¿ø½Ã Àοù¸é, Àü³² °î¼º±º ÀÔ¸é, °æ±â Çϳ²½Ã °¨Àϵ¿, °æºÏ »óÁֽà ¹«¾çµ¿, °æºÏ û¼Û±º û¼ÛÀ¾, Àü³² ´ã¾ç±º ¿ë¸é, ÀÎõ ³²µ¿±¸ ³²Ã̵¿, ÀüºÏ ±º»ê½Ã ȸÇö¸é, °æºÏ ¿¹Ãµ±º °³Æ÷¸é, ¿ï»ê ¿ïÁÖ±º ¾ð¾çÀ¾, °æ±â ¼º³²½Ã ºÐ´ç±¸ ¼®¿îµ¿, °æºÏ ±ºÀ§±º ¼Òº¸¸é, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼ ³»¿øÇÏ°í °è½Ê´Ï´Ù
¼ÛµµÇÑÆ÷ÁøÄ¡·á ãÀ¸½Ã´Â ½ÃÈï, ¹®Çе¿, ÀÛÀüµ¿, ¼þÀǵ¿, »óµ¿, ¼Ò·¡Æ÷±¸, ¼®³²µ¿, ûÇе¿, ¼Ã¢µ¿, °è»êµ¿, ÇÐÀ͵¿, µ¿Ãᵿ, ¼Û¸²µ¿, Áß±¸, ÀÎõ³íÇö, ¼Û¿ùµ¿, ¼Ûµµ, Á־ȿª, ¼Û»ê¸é, ¿¬¼ö±¸, °Ë¾Ï, µµÈµ¿, ¿î¼µ¿, °è¾ç±¸, ¸¸¼öµ¿, ¿¬¼öµ¿, ³íÇö°íÀܵ¿, ³²±¸, µ¿±¸, ¿µÈïµµ, ¼Ûµµ±¹Á¦µµ½Ã, °ü±³µ¿, ¸¶µµ¸é, û¶ó, °£¼®µ¿ µî ¼Ûµµ Áö¿ª Áֹε鲲¼ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù.
´õ »ìÆ캸±â
1. Beck LA, Thaçi D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med 2014; 371:130.
2. Legendre L, Barnetche T, Mazereeuw-Hautier J, et al. Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis. J Am Acad Dermatol 2015; 72:992.
3. Cabana MD, McKean M, Caughey AB, et al. Early Probiotic Supplementation for Eczema and Asthma Prevention: A Randomized Controlled Trial. Pediatrics 2017; 140.
4. www.accessdata.fda.gov/drugsatfda_docs/label/2011/050777s018lbl.pdf (Accessed on July 27, 2017).
5. Bissonnette R, Papp KA, Poulin Y, et al. Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial. Br J Dermatol 2016; 175:902.
6. www.accessdata.fda.gov/drugsatfda_docs/label/2017/761055lbl.pdf (Accessed on April 04, 2017).
7. Hannuksela M, Kalimo K, Lammintausta K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy 1993; 70:127.